Filter posts

Tackling Zika: Q&A With PaxVax CEO Nima Farzan

As mosquito season kicks into high gear and the threat of Zika transmission in the …

Development of a Novel Zika Vaccine with MVA-VLP Technology

Since the World Health Organization (WHO) first designated the Zika virus an international public health …

Lupus Awareness Month: Help Us Solve The Cruel Mystery

Lupus is an unpredictable and misunderstood autoimmune disease that is difficult to diagnose, hard to …

May is Asthma and Allergy Awareness Month

Each year, the Asthma and Allergy Foundation of America (AAFA) works with public and private …

Recap: BIO Stakeholder Briefing on the Medicare Part B Drug Payment Model

On March 8, 2016, the Centers for Medicare and Medicaid Services’ (CMS) Center for Medicare …

Immune Deficiency Foundation: Medicare’s “one size fits all” drug demo is wrong for seniors wi...

Writing yesterday in The Hill, Immune Deficiency Foundation President Marcia Boyle explains the potential harm posed …

Report: Low Compliance with ACA Charity Care Requirements among 340B Hospitals

Earlier this week, the Alliance for Integrity and Reform of 340B, of which BIO is …

Points to Consider about the Center for American Progress Prescription Drug Discussion

This afternoon, the Center for American Progress (CAP) Action Fund hosted an obviously one-sided discussion …

Facing growing pressure, N.Y. insurers agree to lift restrictions on hepatitis c therapies

Last week, we wrote about the mounting evidence of insurer discrimination and coverage denials for …

ICYMI: One Patient’s Perspective: Having Cancer Doesn’t Make Me Worth Less

Yesterday, cancer survivor and health economist Jennifer Hinkel shared her perspective on the Institute for …